Leslie V Norwalk
Director · 8 filings · Latest: Jul 28, 2026
ARVINAS, INC.
CVS HEALTH Corp
GLOBUS MEDICAL INC
NEUROCRINE BIOSCIENCES INC
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
NBIX | Leslie V Norwalk | Director | Jul 29, 2026 | Option Exercise | $139.43 | 842 | $117.4K | 2,430 | |
NBIX | Leslie V Norwalk | Director | Jul 28, 2026 | Sale | $182.01 | 1,250 | $227.5K | 1,588 | |
NBIX | Leslie V Norwalk | Director | Jun 4, 2026 | Sale | $168.06 | 1,250 | $210.1K | 2,838 | |
NBIX | Leslie V Norwalk | Director | May 21, 2026 | Option Exercise | $0.00 | 1,659 | — | 4,088 | |
NBIX | Leslie V Norwalk | Director | May 12, 2026 | Sale | $155.01 | 3,810 | $590.6K | 2,429 | |
NBIX | Norwalk Leslie V | — | May 12, 2026 | Proposed Sale | $162.92 | 6,310 | $1.0M | — | |
GMED | Norwalk Leslie V | — | Jan 8, 2026 | Proposed Sale | $101.00 | 2,000 | $202.0K | — | |
NBIX | Norwalk Leslie V | — | Dec 15, 2025 | Proposed Sale | $155.11 | 11,250 | $1.7M | — | |
GMED | Norwalk Leslie V | — | Dec 12, 2025 | Proposed Sale | $88.75 | 4,000 | $355.0K | — |